Startups

Philly’s $819 million VC quarter: Leveling out to a new norm?

Healthcare companies continue to pull in the largest checks, as the region has a healthy Q1 2024.

Philadelphia skyline as viewed from Camden (Imagic Digital/Mark Henninger)

The Philadelphia region opened the year with a strong start in venture capital deals. After fluctuating quite a bit during the pandemic, the region has taken a more steady influx of VC dollars, and received nearly twice the number in deals than closed in the last quarter of 2023.

Companies from Philly and the surrounding suburbs raised $819 million across 92 deals in Q1 2024, according to the latest Venture Monitor report, released quarterly by PitchBook and the National Venture Capital Association (NVCA).

After the record-breaking year of 2021, the Philly region, like the rest of the country, has begun to level out — but this quarter’s total raise showed an improvement from Q4’s $463 million, in nearly as many deals.

It’s also quite a bit higher than what the area would see pre-pandemic.

Between 2017 and 2019, the Philadelphia Metropolitan Statistical Area, which includes Delaware and parts of New Jersey and Maryland, saw an average quarterly raise of around $460 million, just over half of the latest total. Q1 of this year also outperformed the region’s start one year ago, by 35%.

But it’s a little lower than the outsize numbers from 2021 and early 2022, where it was frequent to see more than $1 billion closing per quarter.

NVCA President and CEO Bobby Franklin believes the slowdown from the pandemic spending is not a trend to be worried about — it’s a reflection on the world and the market at the current moment.

Check out some of the biggest deals in the region below. As always, it’s important to note: These figures may vary slightly after publication, as some deals aren’t accounted for until weeks after quarterly VC reports are published, or PitchBook may find errors in its data.

Philly’s biggest VC deals in Q1 2024

Top regional deals were, as usual, in the healthcare industry, and (somewhat newly) in robotics. They’re spread around the area, with only one based in the city proper.

Here are the four largest, according to PitchBook data and our reporting:

  1. Impulse Dynamics, a South Jersey-based developer of a pacemaker-like device, raised $136 million to grow its commercial reach and its R&D.
  2. Synnovation Therapeutics, a Wilmington-based precision oncology startup, raised $102 million, according to PitchBook data, a few months after its $69.9 million raise in December.
  3. Cagent Vascular, a Wayne-based developer of serration technology, raised $30 million in Series C financing.
  4. Burro, an autonomous vehicles company based in Philadelphia’s Callowhill neighborhood that specializes in machines that work alongside humans at nurseries, vineyards and farms, raised a $24 million series B.

National venture capital trends

Philly’s post-pandemic leveling out in Q1 aligns with what much of the rest of the country experienced, per the latest report.

The nation’s total VC deal count was $36.6 billion across 3,925 total deals, relatively on pace with Q1 of last year, if not a little “to the left of the bell curve than usual,” NVCA’s Franklin said.

The numbers are nothing to worry about, he added, saying the VC business cycle has been “effectively reset” in recent years, and is leveling out in 2024.

Kyle Standford, one of Pitchbook’s lead VC analysts, called Q1 a “calm” quarter, saying that not very many outsized deals were closed, but overall deal count still stayed “relatively” high.

Valuations did rise, likely from a stronger performance of the public markets over the last few months, and the idea that already strong companies will be able to continue to raise in a slower market. Stanford did note that some market uncertainties and inflation have pushed the likelihood of lowered interest rates to the second half of 2024, and a recession “remains a possibility.”

Emily Foote, a partner at Osage Venture Partners, told Technical.ly in January that last year was “defined by investor caution, a painfully slow IPO market, steep valuation resets, and LPs skeptical of VC as an asset class.”

Forte wouldn’t call these “normal” ebs and flows to the market, she said, but rather a “significant market reset that we will likely continue to experience in 2024.”

Companies: Cagent Vascular / Impulse Dynamics / PitchBook / Synnovation Therapeutics / Burro / National Venture Capital Association

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

Trump may kill the CHIPS and Science Act. Here’s what that means for your community.

After nearly a decade, the federal program for immigrant entrepreneurs is finally working

A week before Election Day, some Philly city employees question unexpected website change

Block the bots or feed them facts? How Technical.ly uses AI in journalism

Technically Media